Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer IncfiledCriticalPfizer Inc
Publication of ES8802504A1publicationCriticalpatent/ES8802504A1/en
Publication of ES557634A0publicationCriticalpatent/ES557634A0/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Hypoglycaemic derivatives of 5-[1-(5,6,7,8-tetrahydro-2- naphthyl-,1,2,3,4-tetrahydro-6-quinolyl-,2-indanyl-and 2- indolyl) alkyl] thiazolidine-2,4-dione, their pharmaceutically acceptable salts and a method for their use in the treatment of hyperglycaemic mammals.
3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones oxazolidinones and imidazolidinones as antiinflammatory agents
3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones as antiinflammatory agents